Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-[4-(1-carboxymethyl-2-oxo-propylcarbamoyl)-benzylsulfamoyl]-2-hydroxy-benzoic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the class of beta amino acids and derivatives. It features a sulfonamide group and is structurally related to benzoic acids. The molecule has been studied as an experimental compound, with no current approved medical indications or clinical use. Its mechanism of action includes inhibition of caspase enzymes, specifically caspase‑3, which plays a key role in apoptosis (programmed cell death). This makes it potentially useful for research into apoptosis-related diseases or as a biochemical tool in laboratory settings[5]. There are no known brand names or marketed formulations for this substance.
- Other names
- 5-[4-(1-carboxymethyl-2-oxo-propylcarbamoyl)-benzylsulfamoyl]-2-hydroxy-benzoic acid5-{[(4-{[(2S)-1-carboxy-3-oxobutan-2-yl]carbamoyl}phenyl)methyl]sulfamoyl}-2-hydroxybenzoic acid5-(4-(1-carboxymethyl-2-oxo-propylcarbamoyl)-benzylsulfamoyl)-2-hydroxy-benzoic acidBenzoic acid, 5-[[[[4-[[[(1S)-1-(carboxymethyl)-2-oxopropyl]amino]carbonyl]phenyl]methyl]amino]sulfonyl]-2-hydroxy-
02
Targets
CASP3 (Caspase-3)
Beyond the preview
Go deeper on 5-[4-(1-carboxymethyl-2-oxo-propylcarbamoyl)-benzylsulfamoyl]-2-hydroxy-benzoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-[4-(1-carboxymethyl-2-oxo-propylcarbamoyl)-benzylsulfamoyl]-2-hydroxy-benzoic acid.